The DOI matches its Crossref record; 109 of the 109 references it cites were found in a registry or an index.
Management of treatment-emergent peripheral neuropathy in multiple myeloma
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lenalidomide plus Dexamethasone for Relapsed or Refractory Multiple Myeloma
Dimopoulos, M., Spencer, A., Attal, M., Prince, H. M., Harousseau, J.-L., Dmoszynska, A., Miguel, J. S., Hellmann, A., Facon, T., Foà, R., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070594 · Cited by 1,450
Self-citationLenalidomide plus Dexamethasone for Relapsed Multiple Myeloma in North America
Weber, D. M., Chen, C., Niesvizky, R., Wang, M., Belch, A., Stadtmauer, E. A., Siegel, D., Borrello, I., Rajkumar, S. V., Chanan-Khan, A. A., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070596 · Cited by 1,233
Self-citationRajkumar, S. V., Jacobus, S., Callander, N. S., Fonseca, R., Vesole, D. H., Williams, M. E., Abonour, R., Siegel, D. S., Katz, M., & Greipp, P. R. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(09)70284-0 · Cited by 933
Self-citationMoreau, P., Pylypenko, H., Grosicki, S., Karamanesht, I., Leleu, X., Grishunina, M., Rekhtman, G., Masliak, Z., Robak, T., Shubina, A., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70081-x · Cited by 920
Self-citationFacon, T., Mary, J. Y., Hulin, C., Benboubker, L., Attal, M., Pegourie, B., Renaud, M., Harousseau, J. L., Guillerm, G., Chaleteix, C., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61537-2 · Cited by 869
Self-citationRajkumar, S. V., Blood, E., Vesole, D., Fonseca, R., & Greipp, P. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.0221 · Cited by 865
Self-citationRichardson, P. G., Weller, E., Lonial, S., Jakubowiak, A. J., Jagannath, S., Raje, N. S., Avigan, D. E., Xie, W., Ghobrial, I. M., Schlossman, R. L., et al. (2010) · Blood · doi:10.1182/blood-2010-02-268862 · Cited by 861
Self-citationCavo, M., Tacchetti, P., Patriarca, F., Petrucci, M. T., Pantani, L., Galli, M., Di Raimondo, F., Crippa, C., Zamagni, E., Palumbo, A., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61424-9 · Cited by 819
Self-citationPalumbo, A., Bringhen, S., Caravita, T., Merla, E., Capparella, V., Callea, V., Cangialosi, C., Grasso, M., Rossini, F., Galli, M., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(06)68338-4 · Cited by 809
Self-citationThalidomide and Hematopoietic-Cell Transplantation for Multiple Myeloma
Barlogie, B., Tricot, G., Anaissie, E., Shaughnessy, J., Rasmussen, E., van Rhee, F., Fassas, A., Zangari, M., Hollmig, K., Pineda-Roman, M., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa053583 · Cited by 739
Richardson, P. G., Briemberg, H., Jagannath, S., Wen, P. Y., Barlogie, B., Berenson, J., Singhal, S., Siegel, D. S., Irwin, D., Schuster, M., et al. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.7779 · Cited by 649
Self-citationCombination therapy with lenalidomide plus dexamethasone (Rev/Dex) for newly diagnosed myeloma
Rajkumar, S. V., Hayman, S. R., Lacy, M. Q., Dispenzieri, A., Geyer, S. M., Kabat, B., Zeldenrust, S. R., Kumar, S., Greipp, P. R., Fonseca, R., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2817 · Cited by 648
Self-citationOrlowski, R. Z., Nagler, A., Sonneveld, P., Bladé, J., Hajek, R., Spencer, A., San Miguel, J., Robak, T., Dmoszynska, A., Horvath, N., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.5460 · Cited by 645
Self-citationPostma, T. J., Aaronson, N. K., Heimans, J. J., Muller, M. J., Hildebrand, J. G., Delattre, J. Y., Hoang-Xuan, K., Lantéri-Minet, M., Grant, R., Huddart, R., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.02.012 · Cited by 583
Harousseau, J.-L., Attal, M., Avet-Loiseau, H., Marit, G., Caillot, D., Mohty, M., Lenain, P., Hulin, C., Facon, T., Casassus, P., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.9158 · Cited by 532
Self-citationRichardson, P. G., Blood, E., Mitsiades, C. S., Jagannath, S., Zeldenrust, S. R., Alsina, M., Schlossman, R. L., Rajkumar, S. V., Desikan, K. R., Hideshima, T., et al. (2006) · Blood · doi:10.1182/blood-2006-04-015909 · Cited by 523
Self-citationEvaluation of the Proteasome Inhibitor MLN9708 in Preclinical Models of Human Cancer
Kupperman, E., Lee, E. C., Cao, Y., Bannerman, B., Fitzgerald, M., Berger, A., Yu, J., Yang, Y., Hales, P., Bruzzese, F., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-2766 · Cited by 499
Mateos, M.-V., Oriol, A., Martínez-López, J., Gutiérrez, N., Teruel, A.-I., de Paz, R., García-Laraña, J., Bengoechea, E., Martín, A., Mediavilla, J. D., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70187-x · Cited by 458
Self-citationPalumbo, A., Bringhen, S., Rossi, D., Cavalli, M., Larocca, A., Ria, R., Offidani, M., Patriarca, F., Nozzoli, C., Guglielmelli, T., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2010.29.8216 · Cited by 423
Self-citationDiagnosis, Management, and Evaluation of Chemotherapy-Induced Peripheral Neuropathy
Hausheer, F. H., Schilsky, R. L., Bain, S., Berghorn, E. J., & Lieberman, F. (2006) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.12.010 · Cited by 408
Arastu-Kapur, S., Anderl, J. L., Kraus, M., Parlati, F., Shenk, K. D., Lee, S. J., Muchamuel, T., Bennett, M. K., Driessen, C., Ball, A. J., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-1950 · Cited by 408
Efficacy and safety of once-weekly bortezomib in multiple myeloma patients
Bringhen, S., Larocca, A., Rossi, D., Cavalli, M., Genuardi, M., Ria, R., Gentili, S., Patriarca, F., Nozzoli, C., Levi, A., et al. (2010) · Blood · doi:10.1182/blood-2010-07-294983 · Cited by 381
Self-citationHulin, C., Facon, T., Rodon, P., Pegourie, B., Benboubker, L., Doyen, C., Dib, M., Guillerm, G., Salles, B., Eschard, J.-P., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0948 · Cited by 381
Self-citationPalumbo, A., Bringhen, S., Liberati, A. M., Caravita, T., Falcone, A., Callea, V., Montanaro, M., Ria, R., Capaldi, A., Zambello, R., et al. (2008) · Blood · doi:10.1182/blood-2008-04-149427 · Cited by 358
Self-citationRajkumar, S. V., Rosiñol, L., Hussein, M., Catalano, J., Jedrzejczak, W., Lucy, L., Olesnyckyj, M., Yu, Z., Knight, R., Zeldis, J. B., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.1853 · Cited by 343
Self-citationPalumbo, A., Falco, P., Corradini, P., Falcone, A., Di Raimondo, F., Giuliani, N., Crippa, C., Ciccone, G., Omedè, P., Ambrosini, M. T., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.12.3463 · Cited by 319
Self-citationThalidomide for treatment of multiple myeloma: 10 years later
Palumbo, A., Facon, T., Sonneveld, P., Bladè, J., Offidani, M., Gay, F., Moreau, P., Waage, A., Spencer, A., Ludwig, H., et al. (2008) · Blood · doi:10.1182/blood-2007-10-117457 · Cited by 313
Self-citationRichardson, P. G., Sonneveld, P., Schuster, M. W., Stadtmauer, E. A., Facon, T., Harousseau, J., Ben‐Yehuda, D., Lonial, S., Goldschmidt, H., Reece, D., et al. (2009) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07573.x · Cited by 305
Self-citationMoreau, P., Avet-Loiseau, H., Facon, T., Attal, M., Tiab, M., Hulin, C., Doyen, C., Garderet, L., Randriamalala, E., Araujo, C., et al. (2011) · Blood · doi:10.1182/blood-2011-05-355081 · Cited by 303
Self-citationO'Connor, O. A., Stewart, A. K., Vallone, M., Molineaux, C. J., Kunkel, L. A., Gerecitano, J. F., & Orlowski, R. Z. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0822 · Cited by 295
Self-citationRichardson, P. G., Xie, W., Mitsiades, C., Chanan-Khan, A. A., Lonial, S., Hassoun, H., Avigan, D. E., Oaklander, A. L., Kuter, D. J., Wen, P. Y., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3087 · Cited by 274
Self-citationBuilding on bortezomib: second-generation proteasome inhibitors as anti-cancer therapy
Dick, L. R., & Fleming, P. E. (2010) · Drug Discovery Today · doi:10.1016/j.drudis.2010.01.008 · Cited by 273
Neuropathies Associated with Paraproteinemia
Ropper, A. H., & Gorson, K. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805283382207 · Cited by 270
Bortezomib-induced peripheral neurotoxicity: A neurophysiological and pathological study in the rat
Cavaletti, G., Gilardini, A., Canta, A., Rigamonti, L., Rodriguez-Menendez, V., Ceresa, C., Marmiroli, P., Bossi, M., Oggioni, N., D'Incalci, M., et al. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.11.010 · Cited by 265
Barton, D. L., Wos, E. J., Qin, R., Mattar, B. I., Green, N. B., Lanier, K. S., Bearden, J. D., Kugler, J. W., Hoff, K. L., Reddy, P. S., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0911-0 · Cited by 255
Piva, R., Ruggeri, B., Williams, M., Costa, G., Tamagno, I., Ferrero, D., Giai, V., Coscia, M., Peola, S., Massaia, M., et al. (2008) · Blood · doi:10.1182/blood-2007-07-100651 · Cited by 252
Self-citationGlasmacher, A., Hahn, C., Hoffmann, F., Naumann, R., Goldschmidt, H., von Lilienfeld‐Toal, M., Orlopp, K., Schmidt‐Wolf, I., & Gorschlüter, M. (2006) · British Journal of Haematology · doi:10.1111/j.1365-2141.2005.05914.x · Cited by 237
Treatment-related peripheral neuropathy in multiple myeloma: the challenge continues
Delforge, M., Bladé, J., Dimopoulos, M. A., Facon, T., Kropff, M., Ludwig, H., Palumbo, A., Van Damme, P., San-Miguel, J. F., & Sonneveld, P. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70068-1 · Cited by 222
Self-citationBroyl, A., Corthals, S. L., Jongen, J. L., van der Holt, B., Kuiper, R., de Knegt, Y., van Duin, M., el Jarari, L., Bertsch, U., Lokhorst, H. M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70206-0 · Cited by 219
Self-citationBadros, A., Goloubeva, O., Dalal, J. S., Can, I., Thompson, J., Rapoport, A. P., Heyman, M., Akpek, G., & Fenton, R. G. (2007) · Cancer · doi:10.1002/cncr.22921 · Cited by 217
Mileshkin, L., Stark, R., Day, B., Seymour, J. F., Zeldis, J. B., & Prince, H. M. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.05.6689 · Cited by 211
Ludwig, H., Hajek, R., Tóthová, E., Drach, J., Adam, Z., Labar, B., Egyed, M., Spicka, I., Gisslinger, H., Greil, R., et al. (2009) · Blood · doi:10.1182/blood-2008-07-169565 · Cited by 208
Lacy, M. Q., Hayman, S. R., Gertz, M. A., Short, K. D., Dispenzieri, A., Kumar, S., Greipp, P. R., Lust, J. A., Russell, S. J., Dingli, D., et al. (2010) · Leukemia · doi:10.1038/leu.2010.190 · Cited by 197
Self-citationZonder, J. A., Crowley, J., Hussein, M. A., Bolejack, V., Moore, D. F., Whittenberger, B. F., Abidi, M. H., Durie, B. G. M., & Barlogie, B. (2010) · Blood · doi:10.1182/blood-2010-08-303487 · Cited by 194
Self-citationReeder, C. B., Reece, D. E., Kukreti, V., Chen, C., Trudel, S., Laumann, K., Hentz, J., Pirooz, N. A., Piza, J. G., Tiedemann, R., et al. (2010) · Blood · doi:10.1182/blood-2010-02-271676 · Cited by 190
Bortezomib, melphalan, prednisone, and thalidomide for relapsed multiple myeloma
Palumbo, A., Ambrosini, M. T., Benevolo, G., Pregno, P., Pescosta, N., Callea, V., Cangialosi, C., Caravita, T., Morabito, F., Musto, P., et al. (2007) · Blood · doi:10.1182/blood-2006-08-042275 · Cited by 182
Self-citationKumar, S., Dispenzieri, A., Katzmann, J. A., Larson, D. R., Colby, C. L., Lacy, M. Q., Hayman, S. R., Buadi, F. K., Leung, N., Zeldenrust, S. R., et al. (2010) · Blood · doi:10.1182/blood-2010-06-290668 · Cited by 178
Self-citationCharacteristics of bortezomib‐ and thalidomide‐induced peripheral neuropathy
Chaudhry, V., Cornblath, D. R., Polydefkis, M., Ferguson, A., & Borrello, I. (2008) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2008.00193.x · Cited by 172
Mohty, B., El-Cheikh, J., Yakoub-Agha, I., Moreau, P., Harousseau, J.-L., & Mohty, M. (2010) · Haematologica · doi:10.3324/haematol.2009.012674 · Cited by 167
Self-citationNeurological aspects of multiple myeloma and related disorders
Dispenzieri, A., & Kyle, R. A. (2005) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2005.01.024 · Cited by 161
Richardson, P., Jagannath, S., Hussein, M., Berenson, J., Singhal, S., Irwin, D., Williams, S. F., Bensinger, W., Badros, A. Z., Vescio, R., et al. (2009) · Blood · doi:10.1182/blood-2008-12-196238 · Cited by 158
Self-citationDimopoulos, M. A., Mateos, M., Richardson, P. G. G., Schlag, R., Khuageva, N. K., Shpilberg, O., Kropff, M. H., Špıčka, I., Palumbo, A. P., Wu, K. L., et al. (2010) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2010.01533.x · Cited by 147
Self-citationLokhorst, H. M., Schmidt‐Wolf, I. G. H., Sonneveld, P., van der Holt, B., Martin, H., Barge, R. M. Y., Bertsch, U., Schlenzka, J., Bos, G. M. J., Croockewit, S., et al. (2007) · Haematologica · doi:10.3324/haematol.11644 · Cited by 143
Self-citationPineda-Roman, M., Zangari, M., van Rhee, F., Anaissie, E., Szymonifka, J., Hoering, A., Petty, N., Crowley, J., Shaughnessy, J., Epstein, J., et al. (2008) · Leukemia · doi:10.1038/leu.2008.99 · Cited by 139
Popat, R., Oakervee, H. E., Hallam, S. L., et al. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.06997.x · Cited by 130
Remke, M., Pfister, S. M., Kox, C., Toedt, G., Becker, N., Benner, A., Werft, W., Breit, S., Liu, S., Engel, F., et al. (2009) · Blood · doi:10.1182/blood-2008-10-186536 · Cited by 127
Neuropathy in multiple myeloma treated with thalidomide
Plasmati, R., Pastorelli, F., Cavo, M., Petracci, E., Zamagni, E., Tosi, P., Cangini, D., Tacchetti, P., Salvi, F., Bartolomei, I., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000267271.18475.fe · Cited by 126
Self-citationGay, F., Hayman, S. R., Lacy, M. Q., Buadi, F. K., Gertz, M. A., Kumar, S. K., Dispenzieri, A. A., Mikhael, J. R., Bergsagel, P. L., Dingli, D., et al. (2009) · Blood · doi:10.1182/blood-2009-08-239046 · Cited by 124
Self-citationPoruchynsky, M. S., Sackett, D. L., Robey, R. W., Ward, Y., Annunziata, C. M., & Fojo, T. (2008) · Cell Cycle · doi:10.4161/cc.7.7.5625 · Cited by 110
Mikhael, J. R., Belch, A. R., Prince, H. M., Lucio, M. N., Maiolino, Â., Corso, A., Petrucci, M. T., Musto, P., Komarnicki, M. A., & Stewart, A. K. (2008) · British Journal of Haematology · doi:10.1111/j.1365-2141.2008.07409.x · Cited by 107
Bruna, J., Udina, E., Alé, A., Vilches, J., Vynckier, A., Monbaliu, J. G., Silverman, L. R., & Navarro, X. (2010) · Experimental Neurology · doi:10.1016/j.expneurol.2010.02.006 · Cited by 105
Safety of prolonged therapy with bortezomib in relapsed or refractory multiple myeloma
Berenson, J. R., Jagannath, S., Barlogie, B., et al. (2005) · Cancer · doi:10.1002/cncr.21427 · Cited by 104
Self-citationJohnson, D. C., Corthals, S. L., Walker, B. A., Ross, F. M., Gregory, W. M., Dickens, N. J., Lokhorst, H. M., Goldschmidt, H., Davies, F. E., Durie, B. G. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0792 · Cited by 104
Self-citationOken, M. M., Harrington, D. P., Abramson, N. R., Kyle, R. A., Knospe, W. H., & Glick, J. H. (1997) · Cancer · Cited by 98
Neurological toxicity of long‐term (>1 yr) thalidomide therapy in patients with multiple myeloma
Tosi, P., Zamagni, E., Cellini, C., Plasmati, R., Cangini, D., Tacchetti, P., Perrone, G., Pastorelli, F., Tura, S., Baccarani, M., et al. (2005) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2004.00382.x · Cited by 98
Self-citationClinical and electrophysiological studies in vincristine induced neuropathy.
Pal, P. K. (1999) · PubMed · Cited by 96
Ghobrial, I. M., Weller, E., Vij, R., Munshi, N. C., Banwait, R., Bagshaw, M., Schlossman, R., Leduc, R., Chuma, S., Kunsman, J., et al. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70028-6 · Cited by 95
Self-citationSonneveld, P., Suciu, S., Weijermans, P., Beksaç, M., Neuwirtová, R., Solbu, G., Lokhorst, H. M., der Lelie, J. V., Döhner, H., Gerhartz, H., et al. (2001) · British Journal of Haematology · doi:10.1046/j.1365-2141.2001.03171.x · Cited by 93
Self-citationSonneveld, P., Schmidt‐Wolf, I. G. H., van der Holt, B., el Jarari, L., Bertsch, U., Salwender, H. J., Zweegman, S., Vellenga, E., Schubert, J. E. A., Blau, I. W., et al. (2010) · Blood · doi:10.1182/blood.v116.21.40.40 · Cited by 88
Self-citationLilienfeld‐Toal, M. V., Hahn‐Ast, C., Furkert, K., Hoffmann, F., Naumann, R., Bargou, R. C., Cook, G., & Glasmacher, A. G. (2008) · European Journal Of Haematology · doi:10.1111/j.1600-0609.2008.01121.x · Cited by 77
Millennium Pharmaceuticals, Inc.
(2004) · Personalized Medicine · doi:10.1517/17410541.1.1.131 · Cited by 75
Effective Treatment of Oxaliplatin-Induced Cumulative Polyneuropathy With Alpha-Lipoic Acid
Gedlicka, C., Scheithauer, W., Schüll, B., & Kornek, G. V. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.99.502 · Cited by 72
Zervas, K., Mihou, D., Katodritou, E., Pouli, A. G., Mitsouli, C., Anagnostopoulos, Α., Delibasi, S., Kyrtsonis, M., Anagnostopoulos, N., Terpos, E., et al. (2007) · Annals of Oncology · doi:10.1093/annonc/mdm178 · Cited by 69
Self-citationVelasco, R., Petit, J., Clapés, V., Verdú, E., Navarro, X., & Bruna, J. (2010) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2010.00248.x · Cited by 66
Evidence for direct axonal toxicity in vincristine neuropathy
Silva-Figueroa, A. M., Wang, Q., Wang, M.-S., Ravula, S. K., & Glass, J. D. (2006) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2006.0090.x · Cited by 66
Activation of Wnt5A signaling is required for CXC chemokine ligand 12–mediated T-cell migration
Ghosh, M. C., Collins, G. D., Vandanmagsar, B., Patel, K. G., Brill, M., Carter, A., Lustig, A., Becker, K. G., Wood, W. W., Emeche, C. D., et al. (2009) · Blood · doi:10.1182/blood-2008-08-175869 · Cited by 63
Wolf, J. L., Richardson, P. G. G., Schuster, M. K., et al. (2008) · PubMed · Cited by 61
Self-citationPalumbo, A. P., Delforge, M., Catalano, J. V., Hájek, R., Kropff, M. H., Petrucci, M. T., Yu, Z., Herbein, L., Mei, J. M., Jacques, C. J., et al. (2010) · Blood · doi:10.1182/blood.v116.21.622.622 · Cited by 56
Self-citationColvin, L., Johnson, P. R. E., Mitchell, R., Fleetwood-Walker, S. M., & Fallon, M. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.5017 · Cited by 54
Tariman, J. D., Love, G., McCullagh, E. J., & Sandifer, S. (2008) · Clinical journal of oncology nursing · doi:10.1188/08.cjon.s1.29-35 · Cited by 52
Cavo, M., Raimondo, F. D., Zamagni, E., Patriarca, F. F., Tacchetti, P., Casulli, A. F., Volpe, S., Perrone, G., Ledda, A., Ceccolini, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.7389 · Cited by 50
Self-citationRosiñol, L., Cibeira, M. T., Martínez‐López, J., et al. (2009) · Blood · doi:10.1182/blood.v114.22.130.130 · Cited by 45
Hrusovsky, I., Emmerich, B., von Rohr, A., Voegeli, J., Taverna, C., Olie, R. A., Pliskat, H., Frohn, C., & Hess, G. (2010) · Oncology · doi:10.1159/000322866 · Cited by 44
Siegel, D. D., Sezer, O., Miguel, J. F. S., et al. (2008) · Blood · doi:10.1182/blood.v112.11.2781.2781 · Cited by 43
Self-citationRees, D. C., Lambert, C., Cooper, E., Bartram, J. L., Goss, D. E., Deane, C. R., & Thein, S. L. (2009) · Blood · doi:10.1182/blood-2009-04-216861 · Cited by 41
Visual analogue scales and assessment of quality of life in cancer.
Hauser, K., & Walsh, D. (2008) · PubMed · Cited by 40
Richardson, P. G. G., Siegel, D. S. D., Baz, R., Kelley, S. L., Munshi, N. C., Sullivan, D. M., McBride, L., Doss, D. S., Larkins, G., Jacques, C. J., et al. (2009) · Blood · doi:10.1182/blood.v114.22.301.301 · Cited by 39
Self-citationSiegel, D. S. D., Martin, T. G., Wang, M. L., Vij, R., Jakubowiak, A. J., Jagannath, S., Lonial, S., Kukreti, V., Bahlis, N. J., Alsina, M., et al. (2010) · Blood · doi:10.1182/blood.v116.21.985.985 · Cited by 39
Self-citationAnderson, K. C., Jagannath, S., Jakubowiak, A. J., Lonial, S., Raje, N. S., Alsina, M., Ghobrial, I. M., Knight, R., Esseltine, D. L., & Richardson, P. G. G. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.8536 · Cited by 38
Self-citationKumar, S. K., Flinn, I. W., Richardson, P. G. G., Hari, P., Callander, N. S., Noga, S. J., Stewart, A. K., Glass, J., Rifkin, R. M., Wolf, J. L., et al. (2010) · Blood · doi:10.1182/blood.v116.21.621.621 · Cited by 34
Self-citationCsizmadia, V. (2007) · NeuroToxicology · doi:10.1016/j.neuro.2007.11.003 · Cited by 29
The troublesome toxicity of peripheral neuropathy with thalidomide
Mileshkin, L., & Prince, H. M. (2006) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190600948303 · Cited by 28
Richardson, P. G. G., Hofmeister, C. C., Jakubowiak, A. J., Zimmerman, T. M., Spear, M. A., Palladino, M. A., Longenecker, A. M., Kelly, S. L., Neuteboom, S., Cropp, G. F., et al. (2009) · Blood · doi:10.1182/blood.v114.22.431.431 · Cited by 28
Self-citationFirst-in-human phase I study of the novel structure proteasome inhibitor NPI-0052
Hamlin, P. A., Aghajanian, C. A., Younes, A., Hong, D. S., Palladino, M. A., Longenecker, A. M., Lloyd, G. K., Hannah, A. L., Spear, M. A., & Kurzrock, R. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.3516 · Cited by 18
Miguel, J. F. S., Sezer, O., Siegel, D. S. D., et al. (2009) · Blood · doi:10.1182/blood.v114.22.3852.3852 · Cited by 15
Self-citationBalancing act for elderly myeloma
Palumbo, A. P. (2010) · Blood · doi:10.1182/blood-2010-05-285155 · Cited by 14
Self-citationSequence variation at multiple loci influences red cell hemoglobin concentration
Peters, L. L., Shavit, J. A., Lambert, A. J., Tsaih, S., Li, Q., Su, Z., Leduc, M. S., Paigen, B. J., Churchill, G. A., Ginsburg, D., et al. (2010) · Blood · doi:10.1182/blood-2010-05-283879 · Cited by 14
Richardson, P. G. G., Chanan-Khan, A. A., Lonial, S., et al. (2009) · Blood · doi:10.1182/blood.v114.22.2890.2890 · Cited by 13
Self-citationVoorhees, P. M., Gasparetto, C., Richards, K. L., Garcia, R. A., Strader, J. S., Ferraro, M., MacLean, J., Winans, D., Moore, D. T., Dodd, A., et al. (2009) · Blood · doi:10.1182/blood.v114.22.306.306 · Cited by 11
Self-citationProteasome Inhibitor Associated Neuropathy Is Mechanism Based
Silverman, L. R., Csizmadia, V., Brewer, K., Simpson, C., & Alden, C. L. (2008) · Blood · doi:10.1182/blood.v112.11.2646.2646 · Cited by 9
Tanespimycin + Bortezomib in Relapsed/Refractory Myeloma Patients: Results From the Time-2 Study.
Badros, A. Z., Richardson, P. G. G., Albitar, M. X., et al. (2009) · Blood · doi:10.1182/blood.v114.22.1871.1871 · Cited by 9
Self-citationRosée, P. G. L., Leitner, A., Martiat, P., Klag, T., Shazi, S., Treschl, A., Müller, M. C., Schenk, T., Hanfstein, B., & Hochhaus, A. (2009) · Blood · doi:10.1182/blood.v114.22.1119.1119 · Cited by 9
Khoury, H. J., Mauro, M. J., Matloub, Y., Chen, T., Bahceci, E., & Deininger, M. W. (2009) · Blood · doi:10.1182/blood.v114.22.1128.1128 · Cited by 9
Sonneveld, P., el Jarari, L., Salwender, H. J., Zweegman, S., Vellenga, E., van der Holt, B., Schmidt‐Wolf, I. G. H., Bertsch, U., Schubert, J., Blau, I. W., et al. (2009) · Clinical Lymphoma & Myeloma · doi:10.1016/s1557-9190(11)70667-9 · Cited by 7
Self-citationSiegel, D. S. D., Jagannath, S., Lonial, S., et al. (2009) · Blood · doi:10.1182/blood.v114.22.3890.3890 · Cited by 6
Self-citationRichardson, P. G. G., Bruna, J., Amato, A. A., et al. (2009) · Blood · doi:10.1182/blood.v114.22.3860.3860 · Cited by 5
Self-citationRibosomal Deficiencies Cause Translational Deregulation of Genes Crucial for Erythropoiesis.
Horos, R., IJspeert, H., Taskesen, E., Delwel, R., Pospı́šilová, D., & Lindern, M. V. (2009) · Blood · doi:10.1182/blood.v114.22.179.179 · Cited by 4
Analysis of Viral Integration Sites in Human Induced Pluripotent Stem Cells.
Winkler, T., Cantelina, A. R., Métais, J., Xu, X., Nguyen, A., Wolfsberg, T. G., Antosiewicz‐Bourget, J., Thomson, J. A., & Dunbar, C. E. (2009) · Blood · doi:10.1182/blood.v114.22.1485.1485 · Cited by 2
TIMP–1 Plays a Functional Role in CD34. + Hematopoietic Stem and Progenitor Cells.
Wilk, C. M., Czibere, A. G., Cadeddu, R., Buest, S., Schildberg, F. A., Lauterbach, M. A., Westphal, V., Hell, S. W., Haas, R. R., & Bruns, I. (2009) · Blood · doi:10.1182/blood.v114.22.1487.1487 · Cited by 1
Cited by
Kumar, S. K., Rajkumar, V., Kyle, R. A., van Duin, M., Sonneveld, P., Mateos, M.-V., Gay, F., & Anderson, K. C. (2017) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.46 · Cited by 1,177
Self-citationOral Ixazomib, Lenalidomide, and Dexamethasone for Multiple Myeloma
Moreau, P., Masszi, T., Grzasko, N., Bahlis, N. J., Hansson, M., Pour, L., Sandhu, I., Ganly, P., Baker, B. W., Jackson, S. R., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1516282 · Cited by 1,060
Self-citationEuropean Myeloma Network Guidelines for the Management of Multiple Myeloma-related Complications
Terpos, E., Kleber, M., Engelhardt, M., Zweegman, S., Gay, F., Kastritis, E., van de Donk, N. W. C. J., Bruno, B., Sezer, O., Broijl, A., et al. (2015) · Haematologica · doi:10.3324/haematol.2014.117176 · Cited by 988
Self-citationvan de Donk, N. W. C. J., Pawlyn, C., & Yong, K. L. (2021) · The Lancet · doi:10.1016/s0140-6736(21)00135-5 · Cited by 869
Proteasome inhibitors in multiple myeloma: 10 years later
Moreau, P., Richardson, P. G., Cavo, M., Orlowski, R. Z., San Miguel, J. F., Palumbo, A., & Harousseau, J.-L. (2012) · Blood · doi:10.1182/blood-2012-04-403733 · Cited by 490
Self-citation
Metadata
- Authors
- Richardson, P. G., Delforge, M., Beksac, M., Wen, P., Jongen, J. L., Sezer, O., Terpos, E., Munshi, N., Palumbo, A., Rajkumar, S. V., Harousseau, J. L., Moreau, P., Avet-Loiseau, H., Lee, J. H., Cavo, M., Merlini, G., Voorhees, P., Chng, W. J., Mazumder, A., Usmani, S., Einsele, H., Comenzo, R., Orlowski, R., Vesole, D., Lahuerta, J. J., Niesvizky, R., Siegel, D., Mateos, M.-V., Dimopoulos, M., Lonial, S., Jagannath, S., Bladé, J., Miguel, J. S., Morgan, G., Anderson, K. C., Durie, B. G. M., Sonneveld, P., & on behalf of the International Myeloma Working Group
- Venue
- Leukemia
- Published
- 2011-12-23
- Volume
- 26
- Issue
- 4
- Pages
- 595-608
- ISSN
- 0887-6924 (ISSN-L)
- 1476-5551
- OpenAlex
- W2117237065
- Cited by
- 253
- References
- 109
- FWCI
- 8.82
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.